Melodic Intonation Therapy — NCD 89 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 89 governing melodic intonation therapy coverage, with an effective date of March 7, 2026. Here's what billing teams need to know.

CMS melodic intonation therapy coverage policy under NCD 89 in the Medicare system covers this technique as an outpatient speech-language pathology service — but only for a tightly defined patient population. The policy does not list specific CPT or HCPCS codes. That gap creates real billing risk you need to address before claims go out the door.

Quick-Reference Table

CMS Melodic Intonation Therapy Coverage Criteria and Medical Necessity Requirements 2026

NCD 89 is the National Coverage Determination governing Medicare coverage of melodic intonation therapy. The Centers for Medicare & Medicaid Services classifies it under the Outpatient Speech Language Pathology Services benefit category.

Coverage is narrow. CMS covers melodic intonation therapy only for nonfluent aphasic patients who are unresponsive to conventional therapy. Both conditions must be present — not just one. A patient with nonfluent aphasia who hasn't yet tried conventional speech therapy doesn't qualify. A patient who has tried conventional therapy but isn't nonfluent doesn't qualify either.

The policy language is direct about the evidence base: "limited studies by a few institutions show some benefit for a small number of nonfluent aphasic patients otherwise unresponsive to conventional therapy." CMS is essentially acknowledging that this is a last-resort technique, not a first-line treatment. That framing matters for medical necessity documentation.

Beyond the patient-specific criteria, coverage also requires that all general conditions for Medicare speech pathology services are met. That cross-reference points to the Medicare Benefit Policy Manual, Chapter 15, Sections 220.1 and 230.6. Pull those sections now if your team bills speech-language pathology services — they govern the broader coverage framework that NCD 89 sits inside.

The policy does not mention prior authorization as a specific requirement under NCD 89 itself. However, prior authorization requirements can still apply through your local Medicare Administrative Contractor. Check with your MAC before assuming prior auth isn't needed, especially for a service with this narrow an indication.

Reimbursement for melodic intonation therapy flows through the outpatient speech-language pathology benefit. That means your claims need to reflect both the specific service rendered and the qualifying diagnosis. Get the documentation right at the point of care, not after the fact.

CMS Melodic Intonation Therapy Exclusions and Non-Covered Indications

The coverage policy is restrictive by design. CMS does not cover melodic intonation therapy for fluent aphasia patients. It does not cover it as a first-line treatment when conventional therapy hasn't been tried. And it does not cover it when the standard speech pathology service conditions in Chapter 15 aren't satisfied.

The real issue here is the "unresponsive to conventional therapy" requirement. That phrase does a lot of work. Your documentation needs to show a treatment history — what conventional therapies were tried, for how long, and why they failed. Without that record, you're building a claim on a weak foundation.

CMS's own policy summary describes benefit for only "a small number" of patients. That language signals that CMS will scrutinize these claims. Vague or incomplete medical necessity documentation will produce a claim denial. Be specific in the record about prior treatment attempts and patient response.

Coverage Indications at a Glance

CMS Melodic Intonation Therapy Billing Guidelines and Action Items 2026

The modified coverage policy took effect March 7, 2026. If your practice bills melodic intonation therapy for Medicare patients, these are the steps to take now.

If you're billing this service in volume, or if your practice has a specialty focus in neurological rehabilitation or aphasia treatment, loop in your compliance officer before the effective date has passed you by. The narrow coverage criteria and the absence of specific codes in NCD 89 create ambiguity that's worth resolving proactively.

CPT, HCPCS, and ICD-10 Codes for Melodic Intonation Therapy Under NCD 89

Covered CPT Codes (When Selection Criteria Are Met)

The policy does not list specific CPT or HCPCS codes. CMS's NCD 89 does not assign discrete procedure codes to melodic intonation therapy billing. This is a known gap in the policy.

In practice, melodic intonation therapy is typically billed under speech-language pathology procedure codes. Work with your coding team and MAC to confirm which CPT codes apply to your specific service configuration. Do not assume a code is appropriate without MAC confirmation — coding melodic intonation therapy under an unsupported CPT code is a direct path to a claim denial.

Key ICD-10-CM Diagnosis Codes

No ICD-10 codes are listed in NCD 89. The policy specifies nonfluent aphasia as the qualifying diagnosis in clinical terms, but does not enumerate specific ICD-10-CM codes.

Your coding team should map the appropriate aphasia diagnosis codes from the ICD-10-CM classification. The qualifying diagnosis must reflect nonfluent aphasia specifically — not aphasia in general terms. Get that specificity into the diagnosis field on every claim.